NCT05556642View on ClinicalTrials.gov

Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 7, 2022

Primary Completion Date

September 1, 2032

Study Completion Date

September 1, 2040

Conditions
Relapsed HepatoblastomaRefractory Hepatoblastoma
Interventions
OTHER

Biospecimen collection

Clinical information and biospecimens will be collected

Trial Locations (1)

45229

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER